The antitumor activity of NK012, an SN‐38–incorporating micelle, in combination with bevacizumab against lung cancer xenografts
暂无分享,去创建一个
Y. Nishiwaki | K. Goto | Y. Matsumura | M. Yasunaga | H. Kenmotsu | Y. Koga | J. Kuroda | T. Nagano | Amane Takahashi